Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast

NCT01609400 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01609400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast
Lead sponsor
Galderma R&D
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
August 31, 2013
Enrollment
11 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast enhancement